Equity Profile

BHC

Bausch Health Companies Inc.

Health CarePharmaceuticals$1.8B

Jul29Wed

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

Bausch Health Companies Inc. (BHC) operates in the health care sector, focusing on pharmaceuticals....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

N/A

Revenue Growth

Revenue growth reflects the company's ability to increase sales and expand its market presence, crucial for long-term success.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

BHC Q2-2026 Earnings Preview

Context

Company Snapshot

Bausch Health Companies Inc. (BHC) operates in the health care sector, focusing on pharmaceuticals. The company is known for its diverse portfolio of medical products, including eye health and dermatology treatments, which are essential in addressing various health needs.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

Avg EPS Surprise

-77.46%

Avg Stock Reaction

-1.15%

Last Quarter Recap

In Q1-2026, Bausch Health reported an EPS of $0.78, missing expectations by 3.11%. The stock reacted negatively, declining 1.41% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall expectations for Bausch Health are mixed, given its recent earnings history of missing estimates. Investors are cautious about the company's ability to rebound this quarter.

Bull Case

If Bausch Health can show improved earnings and revenue growth, it may signal a turnaround, attracting investor confidence.

Bear Case

Continued earnings misses could lead to further declines in stock price, as investors lose faith in the company's recovery prospects.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Bausch Health's EPS exceed $0.78 this quarter?

Given the company's recent history of missing EPS estimates, a positive surprise could boost investor confidence.

What is the outlook for revenue growth in key segments?

Understanding revenue trends is crucial for assessing the company's recovery potential and market position.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate Bausch Health's potential for a rebound, as recent product launches could drive unexpected revenue growth.

Supporting Evidence

Options pricing suggests a significant move, indicating that traders expect a reaction regardless of the outcome.

The company's previous earnings history shows volatility, suggesting that a surprise could lead to a larger-than-expected stock movement.

Key Risk

If the EPS comes in above $0.80, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is critical for Bausch Health as it seeks to regain investor trust after a series of earnings misses.

Bull Confirmed If

An EPS of $0.80 or higher would indicate a positive turnaround and validate the bull case.

Bear Confirmed If

An EPS below $0.75 would confirm ongoing struggles and support the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±13.32%

Historical Avg

±2.9%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.

Options are pricing ±13.3% while BHC has averaged ±2.9% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.6%

30d HV

32.3%

Calls (64K)P/C Ratio: 0.10Puts (21K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Bausch Health beats expectations, history suggests a potential stock increase of around 2.9%, confirming a positive trend.

In-Line / Cautious

If results are in line with expectations, the stock may react moderately, reflecting ongoing investor caution.

Miss

Should the company miss again, history indicates a likely decline of approximately 1.15%, further eroding investor confidence.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Management's commentary on cost management and operational efficiency.
3Insights into market share changes in key therapeutic areas.
4Guidance on future earnings expectations and growth strategies.
5Responses to analyst questions regarding competitive pressures.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Jul27

DYNBMO

Dyne Therapeutics, Inc.

PreviewView

Jul27

ARLPBMO

Company Snapshot

Bausch Health Companies Inc. (BHC) operates in the health care sector, focusing on pharmaceuticals....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

N/A

Revenue Growth

Revenue growth reflects the company's ability to increase sales and expand its market presence, crucial for long-term success.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

BHC Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

Avg EPS Surprise

-77.46%

Avg Stock Reaction

-1.15%

Last Quarter Recap

In Q1-2026, Bausch Health reported an EPS of $0.78, missing expectations by 3.11%. The stock reacted negatively, declining 1.41% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall expectations for Bausch Health are mixed, given its recent earnings history of missing estimates. Investors are cautious about the company's ability to rebound this quarter.

Bull Case

If Bausch Health can show improved earnings and revenue growth, it may signal a turnaround, attracting investor confidence.

Bear Case

Continued earnings misses could lead to further declines in stock price, as investors lose faith in the company's recovery prospects.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Bausch Health's EPS exceed $0.78 this quarter?

Given the company's recent history of missing EPS estimates, a positive surprise could boost investor confidence.

What is the outlook for revenue growth in key segments?

Understanding revenue trends is crucial for assessing the company's recovery potential and market position.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate Bausch Health's potential for a rebound, as recent product launches could drive unexpected revenue growth.

Supporting Evidence

Options pricing suggests a significant move, indicating that traders expect a reaction regardless of the outcome.

The company's previous earnings history shows volatility, suggesting that a surprise could lead to a larger-than-expected stock movement.

Key Risk

If the EPS comes in above $0.80, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is critical for Bausch Health as it seeks to regain investor trust after a series of earnings misses.

Bull Confirmed If

An EPS of $0.80 or higher would indicate a positive turnaround and validate the bull case.

Bear Confirmed If

An EPS below $0.75 would confirm ongoing struggles and support the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±13.32%

Historical Avg

±2.9%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.

Options are pricing ±13.3% while BHC has averaged ±2.9% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.6%

30d HV

32.3%

Calls (64K)P/C Ratio: 0.10Puts (21K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Bausch Health beats expectations, history suggests a potential stock increase of around 2.9%, confirming a positive trend.

In-Line / Cautious

If results are in line with expectations, the stock may react moderately, reflecting ongoing investor caution.

Miss

Should the company miss again, history indicates a likely decline of approximately 1.15%, further eroding investor confidence.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Management's commentary on cost management and operational efficiency.
3Insights into market share changes in key therapeutic areas.
4Guidance on future earnings expectations and growth strategies.
5Responses to analyst questions regarding competitive pressures.